Navigation Links
Health Robotics Announces Contract for its CytoCare(TM) and IV Station(TM) Robots With Arabian Health Care Supply Corporation
Date:11/4/2008

acific, and the Middle East. While other companies have for years made promises of robotic IV automation products, and even showcased marketing demonstrations of competing solutions that were supposed to exist as far back as ten years ago, the fact remains that CytoCare(TM) is the only available solution that currently exists anywhere in the world to automatically compound and prepare ready-to-administer hazardous and non-hazardous IV Admixtures, and that has been proven in a "live" hospital pharmacy environment.

"Over the past year Health Robotics has significantly added to its already impressive leadership position in the sector of IV Admixtures Automation. The company has solidified its partnership with B|Braun in some European and Asia-Pacific countries; additionally, very positive dividends are beginning to emerge out of the investments we and our business partners have made with CytoCare(TM) in North America, Middle East and Japan; and lastly, the company has received an unprecedented positive response to the announcement of its non-hazardous IV medications solution IV Station(TM). We are very pleased to be working with such serious partners as AHCSC-OLAYAN. They join a growing list of prestigious health care providers that have adopted our robotic solutions", stated Werner Rainer, CEO of Health Robotics.

"From a customer adoption perspective I would like to share that in the two years since we started this journey, we have installed more IV robots than all of our competitors have sold in over ten years of operations, and we have received purchase orders for one thousand more robots than all of our competitors combined. We are very pleased to see great progress in the hospitals' reception for CytoCare(TM) in new countries such as Germany, Australia, Japan, Taiwan, France, Belgium, Czech Republic, Saudi Arabia, United Arab Emirates, Slovakia, Austria, and also in the United States. I am also pleased to share that extensive tests with thousands of
'/>"/>

SOURCE Health Robotics SRL
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MESA, Calif. , July 24, 2014  Now ... close to home. Rehealth Regenerative Therapies , located ... athletes and other physically active people a new health ... Regardless of age, countless patients suffer from ... sport activities, such as muscle tears, torn rotator cuff, ...
(Date:7/24/2014)... have yet to materialise. Yet, scientists are making ... computers faster. One such approach relies on quantum ... applying an electric field. A new study demonstrates ... quantum dots (TQDs) with electrical impulses can help ... should TQDs be used as quantum information units, ...
(Date:7/24/2014)... California (PRWEB) July 24, 2014 ... to advances in modeling lithium-ion battery storage capacity. ... benefit from a theoretical model created at ... University that predicts how carbon components will ... energy storage emphasizes the urgent need for higher-performance ...
(Date:7/24/2014)... , July 24, 2014  Neogen Corporation (Nasdaq: ... forecasts of its potential revenue from new rodenticide research ... investors and analysts on July 22, 2014, Neogen,s CEO ... regarding this research. "It was my intent ... the potential of a new type of rodenticide, but ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Getting More Life out of Lithium-ion Batteries 2Neogen comments on SenesTech 2
... -- JERUSALEM and NEEDHAM, Massachusetts, August 18, 2010, ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in ...
... Fuels, Inc., a company focused on commercially producing low-carbon ... has produced cellulosic methanol from the initial phase of ... using non-food biomass. The first phase of ... thermo-chemical process, which uses heat, pressure, and steam to ...
... VANCOUVER, Canada, Aug. 17 Xenon Pharmaceuticals Inc. announced ... trial evaluating its novel topical XEN402 therapy for the ... developed by Xenon as a topical ointment formulation and ... 1 study in normal human volunteers.  The product was ...
Cached Biology Technology:Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 2Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 3Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 4Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 5Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 6Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market 7Range Fuels Produces Cellulosic Methanol From First Commercial Cellulosic Biofuels Plant 2Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402. 2
(Date:7/25/2014)... online in the International Journal of Cancer ... cervical cancer based on findings showing successful reduction in ... discrete population of cells in the cervix. , ... squamocolumnar junction cells, or SCJ cells. These cells reside ... the origins of cervical cancer. A research team co-led ...
(Date:7/25/2014)... consume the healthcare community and remain priority ... To address the worldwide crisis of obesity ... global leaders in diabetes, epidemiology and public ... and development of diverse intervention programs in ... This book on "Global Health Perspectives in ...
(Date:7/25/2014)... is a complex congenital central nervous system disease ... the neural tubes during the embryonic phase. Many ... fecal incontinence and neurocognitive retardation. Such problems decrease ... life. Researchers at Ankara Physical Medicine and Rehabilitation ... performance in children with SB, using the Pediatric ...
Breaking Biology News(10 mins):Clearing cells to prevent cervical cancer 2What constitutes an effective response to the global 'diabesity' tsunami? 2
... Emory University's Winship Cancer Institute have identified a novel ... role the marker may play when the tumor spreads ... is elevated in the cerebrospinal fluid of patients with ... in the November issue of Clinical Cancer Research. ...
... that an old and relatively unpopular theory about how a ... accurate after all, and acting in nature. , The finding, ... reassess the process involved in the origin of species. The ... genes that change their locations in a genome. , "In ...
... boost the production of a gassy chemical messenger to dilate ... in unmasking cancer cells so that the immune system can ... Kimmel Cancer Center. , Tests at Hopkins on mice with ... two- and threefold in sildenafil-treated animals, compared to mice that ...
Cached Biology News:Newly identified biomarker detects and regulates spread of brain tumors 2Genetic surprise confirms neglected 70-year-old evolutionary hypothesis 2Genetic surprise confirms neglected 70-year-old evolutionary hypothesis 3'Erectile dysfunction' drugs heighten natural anti-cancer activity 2
... The ProteinChip Antibody Capture ... development and optimization steps ... antibody-antigen interactions. This kit ... differentiation of multiple antigens ...
...
... CLS number is a new product ... product number. If showing no availability ... Sigma-Aldrich number (R4276) or contact customer ... polystyrene (expanded surface, easy grip) ...
... Services offer a full range of peptide ... Services include: Peptide synthesis, crude product ... synthesis, purified product (70-95% pure) ... fluorescein, myristylation, phosphorylation, and rhodamine) ...
Biology Products: